CAPN2 and prostate carcinoma: Meanwhile, calpain-2 was proven to contribute to the methylation of CRMP4′s promoter, repressing its transcription, thereby promoting the metastasis of prostate cancer by enhancing expression of vascular endothelial growth factor C [33].